|
DemazinDrug - Demazin The trade name of the product as shown on the labeling.
Dosage -
TABLET, EXTENDED RELEASE; ORAL
Active Ingredient(s) -
Chlorpheniramine Maleate; Phenylpropanolamine Hydrochloride
Strength -
4MG;25MG
Applicant -
SCHERING PLOUGH
New Drug Application (NDA) Number -
018556
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
May 14, 1984
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Schering Plough Healthcare Products Inc
Demazin
Contac 12 Hour 8mg;75mg Capsule, Extended Release; Oral
Drize 12mg;75mg Capsule, Extended Release; Oral Ornade 12mg;75mg Capsule, Extended Release; Oral Phenylpropanolamine Hcl W/ Chlorpheniramine Maleate 8mg;75mg Capsule, Extended Release; Oral Contac 12mg;75mg Tablet, Extended Release; Oral Demazin 4mg;25mg Tablet, Extended Release; Oral Chloroheniramine Maleate And Phenylpropanolamine Hcl 12mg;75mg Capsule, Extended Release; Oral Chlorpheniramine Maleate And Phenylpropanolamine Hcl 12mg;75mg Capsule, Extended Release; Oral Cold Capsule Iv 12mg;75mg Capsule, Extended Release; Oral Cold Capsule V 8mg;75mg Capsule, Extended Release; Oral NewDrugInformation |